(19)
(11) EP 1 708 710 A1

(12)

(43) Date of publication:
11.10.2006 Bulletin 2006/41

(21) Application number: 05706961.9

(22) Date of filing: 21.01.2005
(51) International Patent Classification (IPC): 
A61K 31/505(2006.01)
(86) International application number:
PCT/EP2005/000602
(87) International publication number:
WO 2005/070431 (04.08.2005 Gazette 2005/31)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR LV

(30) Priority: 22.01.2004 US 538220 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR 
  • Novartis Pharma GmbH
    1230 Vienna (AT)

    AT 

(72) Inventors:
  • BOLD, Guido
    CH-5073 Gipf-Oberfrick (CH)
  • FLOERSHEIMER, Andreas
    CH-4143 Dornach (CH)
  • FURET, Pascal
    F-68800 Thann (FR)
  • IMBACH, Patricia
    CH-4303 Kaiseraugst (CH)
  • MASUYA, Keiichi
    Ibaraki Pref. 300-3257 (JP)
  • SCHOEPFER, Joseph
    CH-4125 Riehen (CH)
  • MARTINY-BARON, Georg
    79336 Herbolzheim (DE)

(74) Representative: Roth, Peter Richard 
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) PYRAZOLO[1,5-A]PYRIMIDIN-7-YL-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES